 |
|
Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke
Chang Ho Ahn, Soo Lim
J Stroke. 2019;21(2):139-150. Published online 2019 May 31 DOI: https://doi.org/10.5853/jos.2019.00038
|
|
Citations to this article as recorded by
 The possible therapeutic role of advanced glycation end-product inhibitors in ischemic stroke
Nada H. Aljarba, Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Mustafa M. Shokr, Marios Papadakis, Athanasios Alexiou, Mubarak Alruwaili, Mohammed Alrouji, Mohammed S. Alshammari, Gaber El-Saber Batiha
Brain Research Bulletin.2025; 222: 111236. CrossRef Stroke in the Patient With Type 2 Diabetes
Terri W. Jerkins, David S.H. Bell
Endocrine Practice.2025;[Epub] CrossRef Exploring epidemiological risk factors for cerebral amyloid angiopathy: Considerations for monoclonal antibody therapy in people with Alzheimer's disease
Liwei Ma, Yihan Wang, Andrew Liem Hieu Huynh, Sanka Amadoru, Scott Wrigley, Paul Yates, Colin L. Masters, Benjamin Goudey, Liang Jin, Yijun Pan
Alzheimer's & Dementia.2025;[Epub] CrossRef Similar incidence of stroke with SGLT2 inhibitors and GLP-1 receptor agonists in real-world cohort studies among patients with type 2 diabetes
André J. Scheen
Diabetes Epidemiology and Management.2024; 13: 100179. CrossRef Comparative Effect of Glucose-Lowering Drugs for Type 2 Diabetes Mellitus on Stroke Prevention: A Systematic Review and Network Meta-Analysis
Ji Soo Kim, Gyeongsil Lee, Kyung-Il Park, Seung-Won Oh
Diabetes & Metabolism Journal.2024; 48(2): 312. CrossRef Amorfrutin B Protects Mouse Brain Neurons from Hypoxia/Ischemia by Inhibiting Apoptosis and Autophagy Processes Through Gene Methylation- and miRNA-Dependent Regulation
Karolina Przepiórska, Agnieszka Wnuk, Cordian Beyer, Małgorzata Kajta
Molecular Neurobiology.2023; 60(2): 576. CrossRef Hyperglycaemic Metabolic Complications of Ischemic Brain: Current
Therapeutics, Anti-Diabetics and Stem Cell Therapy
Vishal Chavda, Snehal Patel
CNS & Neurological Disorders - Drug Targets.2023; 22(6): 832. CrossRef Do SGLT2 inhibitors and GLP-1 receptor agonists modulate differently the risk of stroke ? Discordance between randomised controlled trials and observational studies
André J. Scheen
Diabetes & Metabolism.2023; 49(5): 101474. CrossRef Role of diabetes in stroke: Recent advances in pathophysiology and clinical management
Sian A. Bradley, Kevin J. Spring, Roy G. Beran, Dimitrios Chatzis, Murray C. Killingsworth, Sonu M. M. Bhaskar
Diabetes/Metabolism Research and Reviews.2022;[Epub] CrossRef
|